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no CPXV DNA was amplifiable in the samples from the 
liver, lungs, or environment (online Technical Appendix 
Table 2). 
CPXV infection may manifest in severe ocular forms 
along with self-limiting cutaneous pocks (5). Our patient 
had keratitis with no other identifiable cause but CPXV. 
Culture and PCR from early conjunctival samples and se-
rology confirmed the etiologic diagnosis.
Our case and that of another report (7) highlight the 
challenges of treating cowpox keratitis. Topical and sys-
temic antiviral drugs and AMT appear ineffective during 
the acute phase. Corneal melting and scarring continued 
as long as CPXV was observed and until combined limbal 
stem cell and AMT treatment had favorable outcomes. An-
amnesis of therapy-resistant keratitis should include infor-
mation on rodent contacts.
We dated the infection to mid-August (incubation 
7–21 days). Catching OPV-IgG–positive rodents close to 
the patient’s home 2 months after onset showed that OPVs 
were circulating in the local rodent population and indicat-
ed the putative role of CPXV-infected voles as the source 
of infection.
The latest cowpox outbreak in Central Europe involved 
several humans and pets (8). This patient was born in 
1977, after Finland ceased smallpox vaccinations. Declin-
ing cross-reactive smallpox-vaccination immunity enables 
emergence of unusual cowpox infections in humans (9).
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To the Editor: Human alveolar echinococcosis (AE) 
is a zoonotic parasitic disease caused by larvae of Echino-
coccus multilocularis tapeworms that manifests most often 
in the host’s liver, although it can infect the lungs, brain, 
and other organs. Clinical symptoms usually develop af-
ter a long incubation period (5–15 years), causing consid-
erable diagnostic difficulties and delay in treatment. The 
disease is reported in all countries neighboring the Czech 
Republic:  Slovakia, Poland, Austria, and Germany (1,2). 
To complete data from central Europe, we present results 
on the occurrence of AE in the Czech Republic collected 
by the National Reference Laboratory for Tissue Helmin-
thoses during 2007–2014.
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In the Czech Republic, the occurrence of E. multi-
locularis in definitive (red fox, dog, cat, raccoon dog) and 
intermediate (bank vole) hosts was reported (3). After the 
first reports on detection of the parasites in foxes during 
1995 (4; Figure), physicians started to request laboratory 
examinations for AE in persons with liver lesions, sus-
picious clinical symptoms, or both. During 1998–2014, 
examinations of 1,892 patients revealed 20 AE cases (12 
women, 8 men); the first 2 cases were diagnosed during 
2007 (5,6). In all cases, the diagnosis was based on AE 
characteristic imaging by using ultrasonography, com-
puted tomography, magnetic resonance imaging, or a 
combination of these methods; in 19 (95%) cases, the re-
sults were confirmed by E. multilocularis–specific serol-
ogy. In-house E. multilocularis crude–antigen was used 
for ELISA and Western blot testing and for ELISA IgG 
for detection of E. multilocularis. Em2–Em18 antibod-
ies (Bordier Affinity Products SA, Crissier, Switzerland) 
were used for some laboratory examinations. Since 2009, 
in-house Western blot has been done by using a commer-
cial set (LDBIO, Lyon, France).
In 18 cases, AE was also confirmed by characteristic 
histopathologic findings, species–specific molecular anal-
ysis of tissue biopsies, or both. PCR assay according to 
Schneider et al. (7) has been used in the National Reference 
Laboratory since 2011. In 17 (85%) patients, the liver was 
the only affected organ, and the infection was classified ac-
cording to Brunetti et al. (8) as PN0M0; in 3 patients, liver 
and brain (PN0M1), retroperitoneum (PN1M0), or kidneys 
(PN1M0) were also affected.
Analysis of gender and age at the time of initial AE 
diagnosis showed that the youngest and the oldest pa-
tients were 21 and 82 years old, respectively. To examine 
differences in non–Gaussian distributed variables be-
tween male and female patients, we used the 2-way 
Mann–Whitney nonparametric test (GraphPad, San Di-
ego, CA, USA) to analyze age data. The mean and me-
dian age of patients were lower among women (mean 
45, median 36.5 years) than in men (mean 53, median 60 
years), but these differences were not statistically signifi-
cant (p˃0.05).
According to the site of residence, the patients origi-
nated from different parts of the Czech Republic (Figure). 
The disease was diagnosed in 18 native Czech citizens and 
in 2 citizens from Slovakia.
Physicians interviewed 17 of 20 patients in whom AE 
was diagnosed and completed questionnaires with patient 
data including clinical signs and symptoms, laboratory 
findings, and medical history (e.g., job, hobbies, travels 
abroad, ownership of animals) at the time of the first medi-
cal visit before diagnosis. Ten patients reported a prickling 
sensation and abdominal discomfort or pain. Three patients 
palpated a solid mass in the right hypochondrium before 
physical examination. Another 3 patients reported fever, 
fatigue, or malaise; 1 patient reported weight loss. The first 
clinical examinations by physicians revealed hepatomegaly 
in 16 patients; in addition, 3 of these patients had anemia 
and 1 had jaundice.
In the medical history, dog or cat ownership, garden-
ing, farming, or hunting were recorded in some cases, 
which is similar to what was reported by Kern et al. (10). 
Of 15 persons interviewed who were native to the Czech 
Republic, 6 reported no travel outside the country (Fig-
ure). Because of the occurrence of E. multilocularis in 
animals (Figure), we assume that AE may have a charac-
teristic of autochthonous infection in the Czech Republic. 
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Figure. Distribution of human alveolar 
echinococcosis (AE) in the Czech 
Republic during 2007–2014, according 
to the site of residence of 20 case-
patients, including their travel history. 
Asterisks (*) indicate AE cases already 
published (6,7). Six patients reported 
no travel outside the country; 2 patients 
were born in Slovakia and lived in the 
Czech Republic for 5 and 14 years 
before the time of initial AE diagnosis; 
the remaining patients traveled from the 
Czech Republic to various countries, 
including those to which AE is endemic. 
Nonperiodic examinations of red 
foxes (4,9) revealed the presence 
of Echinococcus multilocularis in 
the country. Date ranges indicate 
the period of examination; numbers 
separated by virgules indicate the 
number of foxes examined and those 
that tested positive, respectively.
The 2 patients from Slovakia lived in the Czech Republic 
for 5 (5) and 14 years, respectively, before the diagnosis of 
AE. Considering the long incubation period of the disease, 
these patients were likely infected in Slovakia, where oc-
currence of AE is also reported (1).
In summary, we report 20 cases of human AE in the 
Czech Republic during 1998–2014. However, because as-
ymptomatic patients with only mild liver involvement are 
unlikely to seek clinical investigation, the actual number of 
patients in the Czech Republic who have AE is expected to 
be even higher than that reported here.
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To the Editor: Underreporting of cases during a large 
outbreak of disease is not without precedent (1–5). Health 
systems in West Africa were ill-prepared for the arrival 
of Ebola virus disease (Ebola) (6). The Ebola outbreak in 
Liberia was declared on March 31, 2014, and peaked in 
September 2014. However, by mid-June, the outbreak had 
reached Montserrado County, where the capital, Monrovia, 
is located. In response, the Liberia Ministry of Health and 
Social Welfare (MOHSW) created a National Ebola Hot-
line: upon receipt of a call, a MOHSW case investigation 
team was dispatched to the site of the possible case. Ad-
ditionally, persons could seek care at an Ebola Treatment 
Unit (ETU) or be referred to an ETU by another health care 
facility. During June 1–August 14, 2014, MOHSW, Méde-
cins Sans Frontières, and the US nongovernment organiza-
tion Samaritan’s Purse managed 3 ETUs in Montserrado 
County, including 2 in Monrovia operated by Eternal Love 
Winning Africa (ELWA).
In August 2014, to assess the extent of underreporting 
in the midst of the Ebola outbreak, we analyzed 2 sources 
of data collected during June 1–August 14. The first com-
prised data collected by MOHSW case investigation teams. 
These data were collected on MOHSW case forms and 
entered into a database emulating these forms using Epi 
Info version 7 software (Centers for Disease Control and 
Prevention, Atlanta, GA, USA). The second data source 
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